HIV Post-Exposure Prophylaxis (PEP): What It Is, When to Start & What to Expect

PEP is a 28-day course of antiretroviral drugs started after potential HIV exposure to prevent infection.

Who Needs PEP

High-risk exposures within the last 72 hours:

  • Condomless anal/vaginal sex with HIV+ partner (or unknown status, high prevalence setting)
  • Needle-sharing with HIV+ person
  • Needlestick injury (healthcare)
  • Sexual assault
  • Exposure to blood/body fluids on mucous membranes/broken skin

Low-risk: oral sex, biting, splashes to intact skin — PEP generally not recommended

Critical Window

  • Start ASAP — ideally within 2 hours, no later than 72 hours
  • Every hour of delay reduces efficacy
  • After 72 hrs, PEP not recommended (but seek testing/counseling)

Standard Regimen (US Guidelines)

  • Preferred: Tenofovir disoproxil fumarate/emtricitabine (Truvada) + raltegravir or dolutegravir
  • Alternative: TAF/FTC (Descovy) + integrase inhibitor
  • Duration: 28 days

Effectiveness & Side Effects

  • Reduces infection risk by >80% (observational data)
  • Not 100% — failures occur with delayed start, resistance, non-adherence
  • Common side effects: nausea, headache, fatigue, diarrhea (usually mild, transient)
  • Rare: liver toxicity, renal impairment (monitor labs at baseline, 2 wks, 4 wks)

Follow-Up

  • HIV testing at baseline, 4–6 weeks, 3 months, 6 months
  • STI screening, pregnancy test if applicable
  • PrEP discussion for ongoing risk
  • Mental health support

Go to an ER or sexual health clinic immediately after exposure. Do not wait for an appointment.

HIV & AIDS - Related Articles